Breaking News Instant updates and real-time market news.

AXGN

AxoGen

$20.15

0.17 (0.85%)

09:33
07/12/19
07/12
09:33
07/12/19
09:33

AxoGen initiated with a Buy at Canaccord

Canaccord analyst Kyle Rose initiated AxoGen with a Buy rating and $32 price target. In a research note to investors, Rose says he believes the investments in the commercial team, market development initiatives and clinical trials position the company to reaccelerate growth into the second half of 2019. Rose says he feels the current valuation represents a compelling entry point, with top-line growth exceeding 30%, a strong balance sheet an an "exceptional" gross margin profile.

  • 09

    Sep

AXGN AxoGen
$20.15

0.17 (0.85%)

05/09/19
CANT
05/09/19
NO CHANGE
Target $30
CANT
Overweight
AxoGen price target raised to $30 from $26 at Cantor Fitzgerald
Cantor Fitzgerald analyst Craig Bijou raised his price target for AxoGen to $30 from $26 saying the company's Q1 growth was a "strong start to the year and a big first step to restore investor confidence." He reiterates an Overweight rating on the shares.
03/25/19
BTIG
03/25/19
UPGRADE
Target $28
BTIG
Buy
AxoGen upgraded to Buy from Neutral at BTIG
BTIG analyst Ryan Zimmerman upgraded AxoGen to Buy with a price target of $28, citing the stabilizing of its sales force based on his analysis of LinkedIn data and expectations that the management will have learned from its past mistakes by offering a more conservative guidance. The analyst also believes that AxoGen could become an M&A target since its potential acquirers have improved leverage ratios and have discussed deploying capital. Moreover, Zimmerman anticipates AxoGen's Avance nerve graft platform to be granted a Biologics License Application status by the FDA, but even in its absence, the analyst contends the company "isn't limited from selling Avance under 361 HCT/P," or Human cells, tissues, or cellular or tissue-based products regulations.
12/19/18
JMPS
12/19/18
NO CHANGE
JMPS
Outperform
JMP says short's suggestion of AxoGen saturation inconsistent with performance
After Seligman Investments distributed a "lengthy" short report on AxoGen that contributed to the stock declining by about 22% yesterday, JMP Securities analyst David Turkaly said he views the three most meaningful remarks as raising potential concerns over the company's previously stated addressable market size, portfolio of intellectual property and current market valuation. However, he believes AxoGen's sales growth, increased rep hiring, active account additions and guidance show that the market saturation suggested by the short report author is inconsistent with recent performance. The short also touched on the regulatory status of Avance, but Turkaly believes AxoGen has been taking adequate steps to successfully progress through its clinical pathway and "constructively communicate" with the FDA, the analyst added. He maintains an Outperform rating and $43 price target on AxoGen shares.
12/19/18
JEFF
12/19/18
NO CHANGE
Target $45
JEFF
Buy
Jefferies disagrees 'on all accounts' with short seller report on AxoGen
AxoGen shares were down 25% yesterday following publication of a short report by Seligman Investments, noted Raj Denhoy. While a point-by-point refutation is not really feasible to a 114 page long report, he disagrees "on all accounts" with the short's claims that AxoGen's products are not differentiated, that the markets for its products are smaller and that the company is worth just a fraction of the stock's current valuation, Denhoy tells investors. Market size has always been a point of debate at AxoGen, but the analyst's work shows that its markets are "far more substantial" than the short seller claims. Additionally, no other company he is aware of is working on bringing a processed nerve allograft to the U.S. market, Denhoy said. He maintains a Buy rating and $45 price target on AxoGen shares.

TODAY'S FREE FLY STORIES

BA

Boeing

$361.17

-8.28 (-2.24%)

, MSFT

Microsoft

$136.29

0.06 (0.04%)

09:09
07/19/19
07/19
09:09
07/19/19
09:09
Hot Stocks
Fly Intel: Pre-market Movers »

HIGHER: AB InBev (BUD),…

BA

Boeing

$361.17

-8.28 (-2.24%)

MSFT

Microsoft

$136.29

0.06 (0.04%)

BUD

AB InBev

$89.38

0.96 (1.09%)

AXP

American Express

$128.40

1.355 (1.07%)

ALV

Autoliv

$69.88

0.04 (0.06%)

KSU

Kansas City Southern

$118.03

1.22 (1.04%)

MIK

Michaels

$8.37

-0.53 (-5.96%)

MAN

ManpowerGroup

$90.30

0.82 (0.92%)

IFRX

InflaRx

$3.12

0.05 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

  • 24

    Jul

  • 25

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 21

    Aug

  • 25

    Sep

  • 13

    Nov

FNV

Franco-Nevada

$89.61

2.02 (2.31%)

09:08
07/19/19
07/19
09:08
07/19/19
09:08
Hot Stocks
Franco-Nevada initiates ATM equity program fo up to $200M »

Franco-Nevada has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLWPF

Flowr

$0.00

(0.00%)

09:08
07/19/19
07/19
09:08
07/19/19
09:08
Syndicate
Flowr withdraws equity offering due to market conditions »

The Flowr Corporation has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

RRC

Range Resources

$5.14

-0.09 (-1.72%)

09:07
07/19/19
07/19
09:07
07/19/19
09:07
Hot Stocks
Range Resources announces assets sales to total $634M »

RANGE RESOURCES announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Aug

FNV

Franco-Nevada

$89.61

2.02 (2.31%)

, RRC

Range Resources

$5.14

-0.09 (-1.72%)

09:07
07/19/19
07/19
09:07
07/19/19
09:07
Hot Stocks
Franco-Nevada acquires Marcellus Shale interest from Range Resources for $300M »

Franco-Nevada (FNV) has…

FNV

Franco-Nevada

$89.61

2.02 (2.31%)

RRC

Range Resources

$5.14

-0.09 (-1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 13

    Aug

DISH

Dish

$40.82

-0.04 (-0.10%)

09:06
07/19/19
07/19
09:06
07/19/19
09:06
Hot Stocks
Dish names Kannan Alagappan as Chief Technology Officer »

Dish announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACU

Acme United

$19.95

0.45 (2.31%)

09:05
07/19/19
07/19
09:05
07/19/19
09:05
Earnings
Acme United backs FY19 EPS guidance $1.41-$1.50, two est. $1.46 »

CEO Walter Johnsen said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

ISRG

Intuitive Surgical

$536.44

13.25 (2.53%)

09:04
07/19/19
07/19
09:04
07/19/19
09:04
Recommendations
Intuitive Surgical analyst commentary  »

Consensus view of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 09

    Sep

WNS

WNS Holdings

$62.34

3.8 (6.49%)

09:03
07/19/19
07/19
09:03
07/19/19
09:03
Recommendations
WNS Holdings analyst commentary  »

WNS Holdings price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Aug

ACU

Acme United

$19.95

0.45 (2.31%)

09:03
07/19/19
07/19
09:03
07/19/19
09:03
Earnings
Acme United reports Q2 EPS 77c, two est. 75c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

NVR

NVR

$3,486.00

-20.17 (-0.58%)

09:01
07/19/19
07/19
09:01
07/19/19
09:01
Earnings
NVR reports Q2 EPS $53.09, consensus $44.82 »

Reports Q2 revenue $1.8B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Aug

UBER

Uber

$43.70

0.08 (0.18%)

09:00
07/19/19
07/19
09:00
07/19/19
09:00
Periodicals
Uber raising prices on Jump dockless electric bikes, Business Insider reports »

Uber is raising prices on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

SKX

Skechers

$34.75

0.35 (1.02%)

08:59
07/19/19
07/19
08:59
07/19/19
08:59
Upgrade
Skechers rating change  »

Skechers upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLB

Schlumberger

$38.78

0.15 (0.39%)

08:58
07/19/19
07/19
08:58
07/19/19
08:58
Hot Stocks
Breaking Hot Stocks news story on Schlumberger »

Schlumberger's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

SLB

Schlumberger

$38.78

0.15 (0.39%)

08:56
07/19/19
07/19
08:56
07/19/19
08:56
Hot Stocks
Schlumberger says North America land 'remains a challenging environment' »

Says: Continues to see…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Aug

  • 13

    Nov

UNP

Union Pacific

$174.15

10.1 (6.16%)

08:56
07/19/19
07/19
08:56
07/19/19
08:56
Recommendations
Union Pacific analyst commentary at Morgan Stanley »

Morgan Stanley stays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

MSFT

Microsoft

$136.29

0.06 (0.04%)

, NFLX

Netflix

$325.14

-37.36 (-10.31%)

08:55
07/19/19
07/19
08:55
07/19/19
08:55
Options
Notable open interest changes for July 19th »

Thursday's total…

MSFT

Microsoft

$136.29

0.06 (0.04%)

NFLX

Netflix

$325.14

-37.36 (-10.31%)

CMCSA

Comcast

$44.56

0.13 (0.29%)

MNST

Monster Beverage

$64.96

-0.77 (-1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 03

    Aug

  • 06

    Aug

  • 08

    Aug

  • 08

    Aug

NFLX

Netflix

$325.14

-37.36 (-10.31%)

, DIS

Disney

$141.62

-0.97 (-0.68%)

08:54
07/19/19
07/19
08:54
07/19/19
08:54
Recommendations
Netflix, Disney analyst commentary  »

Netflix sub losses are…

NFLX

Netflix

$325.14

-37.36 (-10.31%)

DIS

Disney

$141.62

-0.97 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 06

    Aug

DB

Deutsche Bank

$7.93

0.05 (0.63%)

08:47
07/19/19
07/19
08:47
07/19/19
08:47
Conference/Events
Deutsche Bank to hold a conference call »

Management holds the 2Q19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 26

    Jul

SPY

SPDR S&P 500 ETF Trust

$298.86

1.07 (0.36%)

, SPX

S&P 500

$0.00

(0.00%)

08:46
07/19/19
07/19
08:46
07/19/19
08:46
General news
Trump says Federal Reserve thought process 'faulty' »

President Donald Trump…

SPY

SPDR S&P 500 ETF Trust

$298.86

1.07 (0.36%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHA

Aphria

$6.44

-0.12 (-1.83%)

, BZUN

Baozun

$50.05

0.05 (0.10%)

08:45
07/19/19
07/19
08:45
07/19/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

APHA

Aphria

$6.44

-0.12 (-1.83%)

BZUN

Baozun

$50.05

0.05 (0.10%)

CGC

Canopy Growth

$35.79

-0.78 (-2.13%)

UBER

Uber

$43.70

0.08 (0.18%)

PETS

PetMed Express

$16.27

-0.68 (-4.01%)

LK

Luckin Coffee

$19.96

0.46 (2.36%)

ESTC

Elastic

$97.78

1.82 (1.90%)

TECK

Teck Resources

$22.01

-0.21 (-0.95%)

DUST

Direxion Daily Gold Miners Bear 3X ETF

$8.06

-1.2 (-12.96%)

DDS

Dillard's

$64.05

-0.3 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 25

    Jul

  • 26

    Jul

  • 01

    Aug

  • 08

    Aug

YGYI

Youngevity

$4.97

-0.22 (-4.24%)

08:40
07/19/19
07/19
08:40
07/19/19
08:40
Hot Stocks
Youngevity's Khrysos Industries closes $19M supply agreement »

Youngevity executed a one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$71.79

0.95 (1.34%)

08:38
07/19/19
07/19
08:38
07/19/19
08:38
Conference/Events
Citi to host conference call »

CFO Mason & Treasurer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 15

    Oct

SYDDF

Sydney Airport

$0.00

(0.00%)

08:37
07/19/19
07/19
08:37
07/19/19
08:37
Initiation
Sydney Airport initiated at JPMorgan »

Sydney Airport initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEAS

SeaWorld

$33.81

0.38 (1.14%)

08:37
07/19/19
07/19
08:37
07/19/19
08:37
Hot Stocks
SeaWorld elects Charles Koppelman as director, announces board changes »

SeaWorld's Board of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.